ASX:RVA REVA Medical (RVA) Stock Price, News & Analysis → Urgent Nvidia Warning (From Altimetry) (Ad) Free RVA Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get REVA Medical alerts: Email Address Ad Awesomely, LLCAutomatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. About REVA Medical Stock (ASX:RVA)REVA Medical, Inc., a medical device company, focuses on the development and commercialization of polymer-based bioresorbable products for vascular applications. The company offers Fantom Encore, a bioresorbable vascular scaffold for the treatment of coronary artery disease; and MOTIV bioresorbable vascular scaffold for the treatment of below-the-knee peripheral artery disease. It sells Fantom Encore in Germany, Switzerland, Austria, the Netherlands, Belgium, Luxembourg, Italy, and Turkey. The company was formerly known as MD3, Inc. and changed its name to REVA Medical, Inc. in March 2002. REVA Medical, Inc. was founded in 1998 and is headquartered in San Diego, California.Read More Ad Awesomely, LLCAutomatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. RVA Stock News HeadlinesApril 23, 2024 | msn.comReturn of the zombie abortion billsApril 23, 2024 | msn.comHow zombie abortion bills are influencing 2024 fightMay 4, 2024 | Behind the Markets (Ad)Investors Alert: The Next Big Thing in Weight LossUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.April 10, 2024 | msn.comRichmond business approved to sell Kava drinks by Virginia Department of HealthMarch 25, 2024 | msn.comPolice: Woman wearing scrubs stole from Parham Doctors’ Hospital employeesMarch 12, 2024 | msn.comGrand opening of RVA Food Co-Lab, allergen-free culinary hub at Stony Point Fashion ParkMarch 11, 2024 | msn.comThe US is springing forward to daylight saving. For Navajo and Hopi tribes, it’s a time of confusionMarch 8, 2024 | msn.com‘We’re sick and tired’: Richmond’s Southside calls on city to address flooding problemsMay 4, 2024 | Behind the Markets (Ad)Investors Alert: The Next Big Thing in Weight LossUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.March 5, 2024 | msn.comVirginia lawmakers defeat medically assisted suicide billFebruary 7, 2024 | msn.comBill in Virginia giving terminally ill patients choice of when to die advancesJanuary 31, 2024 | msn.comPaid family, medical leave bills advance in VirginiaDecember 19, 2023 | msn.comVHHA launches ‘Control Your Care’ campaign to educate Virginians about laws that benefit patientsNovember 15, 2023 | health.usnews.comSovah Health-DanvilleOctober 6, 2023 | tmcnet.comKeyCare and Remission Medical Join Forces to Increase Access to Virtual Rheumatology Care Across the NationOctober 5, 2023 | washingtonpost.comFirst, the loss of a baby, then the loss of legal rightsAugust 21, 2023 | fool.com.auWhy the Admedus Ltd share price is 14% higher todayAugust 18, 2023 | msn.com‘Glad to see it back’: RVA Bike Share program relaunches on MondayAugust 17, 2023 | msn.comReward offered to help find inmate who escaped Henrico hospitalAugust 14, 2023 | msn.comInsurance rates set to increase for Virginians who are insured using the Affordable Care ActAugust 13, 2023 | msn.comSearch continues for inmate who escaped Henrico hospitalJuly 29, 2023 | investing.comREVA Medical Inc (RVA)July 27, 2023 | msn.comAudit finds Virginia paid nearly $22 million for dead Medicaid patientsJuly 15, 2023 | msn.comForever Summer beer festival headed to RichmondJuly 7, 2023 | msn.comPlaces to beat the heat around RVA this summerJune 28, 2023 | health.usnews.comBon Secours St. Francis Medical CenterJune 28, 2023 | health.usnews.comBest Hospitals in Richmond, VASee More Headlines Receive RVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for REVA Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2018Today5/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:RVA CUSIPN/A CIKN/A Webwww.teamreva.com Phone+1-858-9663000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares414,799,008Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMs. Regina E. Groves (Age 61)CEO & Director Mr. Robert B. Stockman (Age 65)Co-Founder & Director Mr. Jeffrey A. Anderson (Age 52)Sr. VP of Clinical & Regulatory Affairs Ms. Leigh F. Elkolli (Age 47)CFO, Principal Accounting Officer, Corp. Sec. & Corp. Controller Ms. Jessica EarleyVP of Operations & Product Devel.Key Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All Competitors RVA Stock Analysis - Frequently Asked Questions How were REVA Medical's earnings last quarter? REVA Medical Inc (ASX:RVA) released its quarterly earnings data on Tuesday, August, 7th. The company reported $0.61 EPS for the quarter. This page (ASX:RVA) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REVA Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
